Park Avenue Securities’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,599
| Closed | -$178K | – | 1566 |
|
|
2025
Q1 | $178K | Sell |
11,599
-835
| -7% | -$12.8K | ﹤0.01% | 1135 |
|
|
2024
Q4 | $274K | Buy |
12,434
+2,341
| +23% | +$51.6K | ﹤0.01% | 1319 |
|
|
2024
Q3 | $182K | Sell |
10,093
-1,546
| -13% | -$27.9K | ﹤0.01% | 1349 |
|
|
2024
Q2 | $189K | Sell |
11,639
-5,936
| -34% | -$96.4K | ﹤0.01% | 1321 |
|
|
2024
Q1 | $248K | Buy |
+17,575
| New | +$248K | ﹤0.01% | 1244 |
|
|
2022
Q4 | – | Sell |
-11,850
| Closed | -$96K | – | 1218 |
|
|
2022
Q3 | $96K | Buy |
+11,850
| New | +$96K | ﹤0.01% | 1096 |
|